Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy

Beta Blockers with Statins May Decrease All-Cause Mortality in Patients with Cardiovascular Diseases and Locally Advanced Unresectable Non-Small-Cell Lung Cancer after Chemoradiotherapy

The study was conducted in the era when maintenance immunotherapy with durvalumab was not available in clinical practice after chemoradiotherapy (CRT) in unresectable non-small-cell lung cancer (NSCLC). The main aim of the study was to check whether the presence of cardiovascular diseases (CVD) and...

Full description

Bibliographic Details
Main Authors: Magdalena Zaborowska-Szmit, Sebastian Szmit, Marta Olszyna-Serementa, Paweł Badurak, Katarzyna Zajda, Anna Janowicz-Żebrowska, Aleksandra Piórek, Magdalena Knetki-Wróblewska, Piotr Jaśkiewicz, Adam Płużański, Maciej Krzakowski, Dariusz M. Kowalski
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Cancers
Subjects:
lung cancer
mortality
cardiovascular diseases
beta blocker
statin
cardio-oncology
Online Access:https://www.mdpi.com/2072-6694/15/4/1277

Internet

https://www.mdpi.com/2072-6694/15/4/1277

Similar Items